Use access key #2 to skip to page content.
  • S&P 500: 1,069.30
  • Change: 0.25%
$32.59 -0.12 (-0.37%)
11/6/2009 4:00 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MRK

Add Stock to Watchlist

What the Community Thinks

Total Members

2301 Outperforms
180 Underperforms
 

All-Stars

617 Outperforms
38 Underperforms
 

Wall Street

25 Outperforms
1 Underperforms
 

Members bullish on MRK are also bullish on:

Members bearish on MRK are also bearish on:

Ticker Tags

Pharmaceuticals (153), Major 2005 Lawsuit (6), S&P 500 (500), SEC investigation (6), Dow (29), Multinational Company (15), Healthcare (737), Optionable (25), Income (1520), Major 2006 Lawsuit (3), New Jersey (6), Big Pharma (10), Growth (1896), Dividend (191), Blue Chip (121), Mega Cap (113), Defensive (1498)
Suggest a tag

Merck & Co., Inc. At A Glance

Current Price: $32.59
Last Trade Time: 11/6/2009 4:00 PM
Open: $32.61
Previous Close: $32.71
Daily Range: $32.22 - $32.95
52-Week Range: $31.25 - $33.43
Volume: 19,844,328
Market Cap: $53.42B
P/E Ratio: 8.56
Compare Our Special Broker Offers!

Stock Trends

MRK VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for MRK

More Headlines...

Top Bull Pitch

Recs

6

Merck & Co., Inc. (MRK)

Avatar SeattleRoses (96.42) Submitted: 8/17/09 4:45 PM

Technical trends indicate upcoming bullish pattern. This 4-star stock is about to pop!

Narrowing of the Bollinger Bands over the past couple of weeks suggests a significant price movement will soon occur.

The rising 50-day moving average above the 200-day moving average is signifying a bullish pat...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

Merck & Co., Inc. (MRK)

Avatar 3kidsjones (72.39) Submitted: 10/07/06 8:43 AM

Has had a nice run-up recently, but too many problems ahead for this major pharma to sustain the trend...look out below

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 373 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

1

 (MRK)

Avatar thackm (43.31) Submitted: 11/04/09 11:54 AM : Outperform Start Price: $32.37 MRK Score: -0.56

with the merger to SGP. only good things ahead for this stock.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (MRK)

Avatar jcn2u (62.79) Submitted: 10/31/09 7:23 PM : Outperform Start Price: $38.92 MRK Score: -2.40

They bought SGP on the cheap.
SGP has the pipeline and management that MRK needed.
MRK has the deep pockets to carry through with the drugs in the pipeline, SGP did not.
Now the question is:
Does MRK have the fortitude to do what has to be done with their own management.
We shall see.
IF done correctly MRK has the raw materials to become THE dominate drug company that they were many years ago.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (MRK)

Avatar luremaster (< 20) Submitted: 10/31/09 2:03 PM : Outperform Start Price: $31.12 MRK Score: 1.84

after buyout will have large cost savings and little overlap of products and a better pipeline of new drugs.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (MRK)

Avatar gtcircus (67.37) Submitted: 10/30/09 11:10 AM : Outperform Start Price: $31.69 MRK Score: 1.48

health care leader pt 2

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (MRK)

Avatar Boredkid (85.74) Submitted: 10/27/09 2:07 AM : Outperform Start Price: $32.59 MRK Score: -0.09

Low P/E, high dividend yield. Expect patent-losses affect on bottom line to be offset by acquisitions and partnerships; also expect Wall Street to be overly pessimistic about patent expirations.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 373 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 26 of 26  

picks per page. CHANGE Expand All Pitches

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackJohnRogers < 20 09/23/09 Outperform 1Y $31.39+3.82%-0.18%+4.00 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 04/27/09 Underperform 3W $22.84+42.67%+26.11%-16.56
TrackTobinSmith < 20 04/24/09 Outperform 1Y $22.85+42.61%+24.92%+17.69
TrackBarclaysCap 86.02 12/05/08 Outperform NS $23.32+39.76%+32.19%+7.57
TrackUBS 86.41 10/17/08 Outperform NS $26.02+25.24%+19.48%+5.76
TrackRichPzena < 20 09/30/08 Outperform NS $29.82+9.29%-5.25%+14.54 Toggle the visibility of 60-Second Pitch and replies
TrackJPMorgan 78.71 06/25/08 Outperform NS $34.35-5.12%-16.08%+10.96
TrackHAndW 23.63 03/31/08 Outperform NS $35.11-7.18%-14.91%+7.73 Toggle the visibility of 60-Second Pitch and replies
TrackNWQ < 20 03/31/08 Outperform NS $35.11-7.18%-14.91%+7.73 Toggle the visibility of 60-Second Pitch and replies
TrackGaryBSmith 41.83 10/26/07 Outperform 3W $52.49-37.91%-26.94%-10.97
TrackBernstein 86.97 10/24/07 Outperform NS $51.37-36.56%-25.77%-10.79
TrackSnow 94.97 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.26 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 96.65 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackHillman 91.15 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 86.63 09/30/07 Outperform NS $47.12-30.83%-26.44%-4.39 Toggle the visibility of 60-Second Pitch and replies
TrackBofASec 93.50 09/13/07 Outperform NS $46.03-29.20%-24.08%-5.12
TrackCowenandCo 74.62 08/06/07 Outperform NS $46.32-29.63%-21.80%-7.84
TrackAGEdwards 89.12 07/12/07 Outperform NS $45.08-27.70%-26.25%-1.45
TrackBMOCapital 86.09 04/13/07 Outperform NS $44.92-27.45%-21.62%-5.84
TrackScottBleier 63.76 04/13/07 Outperform 3M $45.08-27.71%-22.06%-5.65
TrackCitigroup 21.22 02/26/07 Outperform NS $39.47-17.44%-22.03%+4.59
TrackBearStearns 86.38 01/03/07 Outperform NS $39.20-16.86%-20.06%+3.21
TrackDeutscheSec 89.50 10/24/06 Outperform NS $40.68-19.90%-17.17%-2.73
TrackLehmanBros 76.60 08/21/06 Outperform NS $35.61-8.48%-12.19%+3.71

Results 1 - 26 of 26  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 968ms